Martensen IP Offers Strategic Insights on How Defense and Tech Contractors Can Navigate FAR and DFARS Without Surrendering Their Intellectual Property

Martensen IP argues that startups can use non-dilutive federal R&D funding to develop dual-use aerospace, software and deep-tech products while retaining commercial IP ownership, subject to government-use licenses. The article highlights FAR and DFARS data-rights rules, warning that fully government-funded development can result in unlimited government rights and that unmarked technical data may be presumed delivered with unlimited rights. It cites Elroy Air's use of military prototyping funds alongside protected commercial IP as a model for building logistics-sector pre-orders and maintaining defense-contract eligibility.

Analysis

This is not a public-markets catalyst; it is law-firm marketing around an established contracting issue, with no independently verifiable change in appropriations, procurement policy, or award activity. The investable signal is therefore limited. Investors should avoid extrapolating generic dual-use funding narratives into near-term revenue for defense-tech proxies without evidence of funded programs, production contracts, or commercial customer conversion.

The more relevant second-order risk is concentrated in private dual-use companies: poor segregation of privately funded and government-funded development can impair commercial licensing value precisely when firms seek late-stage capital or strategic buyers. That creates an eventual advantage for scaled primes such as LMT, NOC and RTX, which can absorb compliance overhead and may gain access to smaller suppliers' technology where startups mismanage data rights. Conversely, public companies with material government software exposure—PLTR, KTOS and AVAV—should be evaluated contract-by-contract for whether awards support proprietary product economics rather than bespoke, government-funded deliverables.

Over 6-18 months, a sustained shift toward prototyping and rapid fielding would favor suppliers with repeatable commercial product architectures, but it can also compress margins if agencies demand broad technical-data rights or competitive recompetes. The thesis is falsified by evidence that prototype awards convert into restricted-source production contracts with protected data rights and expanding gross margins; absent that, announced awards remain weak indicators of durable enterprise value.

Key Decisions for Investors

• No directional trade on this item; treat it as a diligence flag rather than a catalyst.
• For any private defense-tech financing or public small-cap defense position, require a data-rights audit: funding-source records, asserted markings, background-IP schedule, and whether the government can provide technical data to recompete. Do not underwrite commercial-IP multiples without this evidence.
• Maintain preference for LMT/NOC/RTX over pre-profit dual-use venture exposure where procurement timelines lengthen: primes have balance-sheet capacity and installed-program leverage, while startups face financing risk before follow-on awards. Reassess if rapid-production awards visibly shift toward smaller vendors.
• Monitor PLTR, KTOS and AVAV earnings for backlog conversion, gross-margin trajectory, and customer concentration rather than headline contract values. A widening gap between bookings and revenue conversion over the next 1-3 quarters would argue against adding exposure.